Aurobindo Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 19	Mar ' 18

Profit before tax

1,614.35

1,637.48

4,193.01

1,964.62

2,342.94

Net cashflow-operating activity

1,821.16

3,726.71

2,994.41

526.71

922.40

Net cash used in investing activity

-3,459.68

-1,613.51

-2,648.73

-1,297.36

-990.60

Netcash used in fin. activity

1,719.48

-2,447.54

-27.94

599.40

439.69

Net inc/dec in cash and equivlnt

81.44

-335.37

316.23

-171.25

371.49

Cash and equivalnt begin of year

48.21

383.58

67.35

239.95

-131.54

Cash and equivalnt end of year

129.65

48.21

383.58

68.70

239.95